Current problems of perinatal Chlamydia trachomatis infections

Journal of Immune Based Therapies and Vaccines

Volumn 2, Issue , 2004, Pages

  Numazaki, Kei ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antigenic variation; Chlamydia trachomatis; Eye diseases; Serovars

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL ANTIGEN; GAMMA INTERFERON; METRONIDAZOLE;

BACTERIAL IMMUNITY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; CONJUNCTIVITIS; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; EYE INFECTION; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; INFANT; INFECTION RISK; NEWBORN; NEWBORN DISEASE; NONHUMAN; PERINATAL INFECTION; PREGNANCY DISORDER; PREMATURITY; REVIEW; RHINOPHARYNGITIS; RISK ASSESSMENT; SCREENING TEST; SERODIAGNOSIS; TREATMENT PLANNING; UTERINE ENDOCERVIX;

EID: 4243126881     PISSN: 14768518     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-8518-2-4     Document Type: Review

References (52)

1. Numazaki K, Wainberg MA, McDonald J: Chlamydia trachomatis infections in infants. CMAJ 1989, 140:615-622.
2. Numazaki K, Chiba S, Yamanaka T, Umetsu M, Nakao T: Pneumonia due to Chlamydia trachomatis in Japanese infants. Tohoku J exp Med 1984, 143:413-420.
3. Numazaki K, Chiba S, Umetsu M: Detection of IgM antibodies to Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia psittaci from Japanese infants and children with pneumonia. In vivo 1992, 6:601-604.
4. Numazaki K, Asanuma H, Niida Y: Chlamydia trachomatis infection in early neonatal period. BMC Infectious Diseases 2003, 3:2.
5. Bailey R, Duong T, Carpenter R, Whittle H, Mabey D: The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect 1999, 123:479-486.
6. Rothermel CD, Schachter J, Lavrich P, Lipsits EC, Francus T: Chlamydia trachomatis - induced production of interleukin-1 by human monocytes. Infect Immun 1989, 57:2705-2711.
7. Bailey RL, Holland MJ, Whittle HC, Mabey DC: Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect Immun 1995, 63:389-392.
8. Holland MJ, Bailey RL, Hayes LJ, Whittle HC, Mabey DC: Conjunctival scarring in trachoma is associated with depressed cellmediated immune responses to chlamydial antigens. J Infect Dis 1993, 168:1528-1531.
9. Beatty WL, Belanger TA, Desai AA, Morrison RP, Byrne GI: Tryptophan depletion as a mechanism of gamma interferonmediated chlamydial persistence. Infect Immun 1994, 62:3705-3711.
10. Young E, Taylor HR: Immune mechanisms in chlamydial eye infection: cellular immune response in chronic and acute disease. J Infect Dis 1984, 150:745-751.
11. Mabey DCW, Holland MJ, Viswalingam ND, Goh BT, Estreich S, Macfarlane A, Dockrell HM, Treharne JD: Lymphocyte proliferative responses to chlamydial antigens in human chlamydial eye infections. Clin exp Immunol 1991, 86:37-42.
12. Peeling RW, Brunham RC: Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 1996, 2:307-319.
13. Nakajo MN, Roblin PM, Hammerschlag MR, Smith P, Nowakowski M: Chlamydicidal activity of human alveolar macrophages. Infect Immun 1990, 58:3640-3644.
14. Chen JC, Stephens RS: Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan-dependent mechanism for infection of eukaryotic cells Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan-dependent mechanism for infection of eukaryotic cells. Molecular Microbiology 1994, 11:501-507.
15. Manor E, Sarov I: Fate of Chlamydia trachomatis inhuman monocytes and monocytes-derived macrophages. Infect Immun 1986, 54:90-95.
16. Yong EC, Chi EY, Kuo C-C: Differential antimicrobial activity of human mononuclear phagocytes against the human biovars of Chlamydia trachomatis. J Immunol 1987, 139:1297-1302.
17. Pal S, Fielder TJ, Peterson EM, de la Maza LM: Analysis of the immune response in mice following intrauterine infection with the Chlamydia trachomatis is mouse pneumonitis biovar. Infect Immun 1993, 61:772-776.
18. Morrison RP, Lyng K, Caldwell HD: Chlamydial disease pathogenesis: ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med 1989, 169:663-675.
19. Peeling RW, Bailey RL, Conway DJ et al.: Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma. J Infect Dis 1998, 177:256-259.
20. Wang S-P, Grayston JT: Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis 1974, 130:388-397.
21. Yuan Y, Zhang YX, Watkins NG, Caldwell HD: Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun 1989, 57:1040-1049.
22. Frost EH, Deslandes S, Veilleux S, Bourgaux-Ramoisy D: Typing Chlamydia trachomatis by detection of restriction fragment lengthpolymorphism in the gene encoding the major outer membraneprotein. J Infect Dis 1991, 163:1103-1107.
23. Hayes LJ, Bailey RL, Mabey DCW, Clarke IN, Pickett MA, Watt PJ et al.: Genotyping of Chlamydia trachomatis from a trachomaendemic village in the Gambia by a nested polymerase chain reaction: identification of strain variants. J Infect Dis 1992, 166:1173-1177.
24. Jonsdottir K, Kristjansson M, Hjaltalin Olafsson J, Steingrimsson : The molecular epidemiology of genital Chlamydia trachomatis in the greater Reykjavik area, Iceland. Sex Trans Dis 2003, 30:249-256.
25. Caldwell HD, Wood H, Crane D, Bailey R, Jones RB, Mabey D et al.: Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest 2003, 111:1757-1769.
26. Yang CL, Maclean I, Brunham RC: DNA sequence polymorphism of the Chlamydia trachomatis omp1 gene. J Infect Dis 1993, 168:1225-1230.
27. Sayada C, Denamur E, Xerri B, Orfila J, Catalan F, Elion J: Epidemiology of Chlamydia trachomatis using analysis of gene encoding of the major outer membrane protein. Pathol Biol 1992, 40:583-589.
28. Arno JN, Xie C, Jones RB, van der Pol B: Identification of T cells that respond to serovar-specific regions of the Chlamydia trachomatis major outer membrane protein in persons with serovar E infection. J Infect Dis 1998, 178:1713-1718.
29. Dean D, Millman K: Molecular and mutation trends analysis of omp1 alleles for serovar E of Chlamydia trachomatis. J Clin Invest 1997, 99:475-483.
30. Isobe K, Aoki K, Itoh N, Ohno S, Takashima I, Hashimoto N: Serotyping of Chlamydia trachomatis from inclusion conjunctivitis by polymerase chain reaction and restriction fragment length polymorphism analysis. Jpn J Ophthalmol 1996, 40:279-285.
31. Numazaki K, Suzuki K, Isobe K, Nakada H, Niida Y, Chiba S: Typing of Chlamydia trachomatis from Japanese infants with pneumonia byrestriction fragment length polymorphism. Scand J Infect Dis 1996, 28:209.
32. Toyofuku H, Takashima I, Arikawa J, Hashimoto N: Monoclonal antibodies against Chlamydia psittaci. Microbiol Immunol 1986, 30:945-955.
33. Seki C, Takashima I, Arikawa J, Hashimoto N: Monoclonal antibodies to Chlamydia psittaci: characteristics and antigenic analysis. Jpn J Vet Sci 1988, 50:383-393.
34. Wang S-P, Kuo C-C, Barnes RC, Stephens RS, Grayston JT: Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis 1985, 152:791-800.
35. Gencay M, Koskiniemi M, Saikku P, Puolakkainen M, Raivio K, Koskela P, Vaheri A: Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infect Dis 1995, 21:424-426.
36. Numazaki K, Ikehata M, Akashi E, Kusaka T, Chiba S: Seropositivity to Chlamydia trachomatis during pregnancy and perinatal complications. J Infect Chemother 1998, 4:28-31.
37. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA: A case-control study of chorioamniotic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988, 319:972-978.
38. Numazaki K, Chiba S, Kogawa K, Umetsu M, Motoya H, Nakao T: Chronic respiratory disease in premature infants caused by Chlamydia trachomatis. J Clin Pathol 1986, 39:84-89.
39. Adams MM, Elam-Evans LD, Wilson HG, Gilbertz DA: Rates of and factors associated with recurrence of preterm delivery. JAMA 2000, 283:1591-1596.
40. Carey JC, Klebanoff MA, Hauth JC et al.: Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000, 342:534-540.
41. Lamont RF: Antibiotics for the prevent of preterm birth. N Engl J Med 2000, 342:581-582.
42. Holzman C, Jetton J, Fisher R, Senagore P, Mohan M, Paneth N: Association of maternal IgM concentrations above the median at 15 - 19 weeks of gestation and early preterm delivery. Lancet 1999, 354:1095-1096.
43. Numazaki K, Chiba S, Niida Y, Komatsu M, Hashimoto N: Evaluation of diagnostic assays for neonatal and infantile chlamydial infections. Tohoku J exp Med 1993, 170:123-129.
44. Numazaki K, Niida Y, Chiba S: Antigen detection of Chlamydia trachomatis from the endocervix is not enough for screening of perinatal complications. Am J Obstet Gynecol 1997, 174:951-952.
45. Treharne JD: The community epidemiology of trachoma. Rev Infect Dis 1985, 7:760-764.
46. Faal H, Minassian D, Sowa S, Foster A: National survey of blindness and low vision in the Gambia: results. Br J Ophthalmol 1989, 73:82-87.
47. Mabey DC, Solomon AW, Foster A: Trachoma. Lancet 2003, 362:223-229.
48. Lietman T, Porco T, Dawson C, Blower S: Global elimination of trachoma: How frequently should we administer mass chemotherapy? Nat Med 1999, 5:572-576.
49. Taylor HR: A simple method for assessment of association between synanthropic flies and trachoma. Am J Trop Med Hyg 1988, 38:623-627.
50. Emerson PM, Lindsay SW, Walraven GEL, Faal HB, Claus L, Kebba B, Robin L: Effect of fly control on trachoma and diarrhoea. Lancet 1999, 353:1401-1403.
51. Schachter J, West SK, Mabey D et al.: Azithromycin in control of trachoma. Lancet 1999, 354:630-635.
52. Numazaki K, Ikehata M, Chiba S, Aoki K: Reduction of trachoma in absence of a disease-control programme. Lancet 1997, 350:447-448.